Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies
Barbara Ink, Jason Coarse, A. Asahina, Rajan Bajracharya et al.
Journal
Lara D. Veeken
Topics
Spondyloarthritis Studies and Treatments
article
Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies
Barbara Ink, Jason Coarse, A. Asahina, Rajan Bajracharya, Myriam Manente, Fabian Proft, Nadine Goldammer, Christopher T Ritchlin, Laura C Coates, Joseph F Merola, Yoshiya Tanaka, Iain B McInnes, Laure Gossec, Philip J Mease, Robert B M Landewé
article en
Abstract
No abstract available for this paper.
Publication Tag
Lara D. Veeken
Institutions
Jikei University School of Medicine (JP), Inserm (FR), University of Occupational and Environmental Health Japan (JP), North Carolina Institute of Medicine (US), Nuffield Orthopaedic Centre (GB), University of Rochester Medical Center (US), University College Birmingham (GB), Humboldt-Universität zu Berlin (DE), Sorbonne Université (FR), Swedish Medical Center (US), Southwestern Medical Center (US), Pitié-Salpêtrière Hospital (FR), Zuyderland Medisch Centrum (NL), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Oxford University Hospitals NHS Trust (GB), UCB Pharma (Germany) (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), University of Glasgow (GB), UCB Pharma (Belgium) (BE), The University of Texas Southwestern Medical Center (US)